Analyst Ratings for CytomX Therapeutics (CTMX)
CTMX Rating Summary
CTMX Price Target Summary
- Highest: $10.00 (H.C. Wainwright)
- Lowest: $7.00 (Oppenheimer)
- Average: $9.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$9.50 (+103%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 76%
Avg. $ Target:
$9.50 (+103%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 76%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/20/2026 | Guggenheim | Michael Sch | New Coverage | Buy (N/A) |
10.00 (N/A) |
5.39 (4.68) |
-13.17% | Details |
| 9/22/2025 | Cantor Fitzgerald » Updated 2/4/2026 |
Olivia Brayer | New Coverage | Overweight (N/A) |
10.00 (6.00) |
1.98 (4.68) |
136.36% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
